We are live on ! Find out more
MTFBW

Motif Bio plc Warrants to Purchase ADRs
MTFBW

Delisted

MTFBW was delisted on the 16th of December, 2019.

Back to rankings

3 hedge funds and large institutions have $2.56M invested in Motif Bio plc Warrants to Purchase ADRs in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

51% more capital invested

Capital invested by funds: $1.7M → $2.56M (+$863K)

50% more funds holding

Funds holding: 2 → 3 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SGCM
Sand Grove Capital Management
United Kingdom
+$404K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$881
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
1
Invesco
Georgia
$2.18M – – –
SGCM
2
Sand Grove Capital Management
United Kingdom
$372K +$404K +97,200 New
UBS Group
3
UBS Group
Switzerland
$4K -$881 -212 -18%

MTFBW Hedge Fund Activity: Q4 2017 in Review

3 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q4 2017, worth a combined $2.56M — up 51% from $1.7M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new MTFBW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Sand Grove Capital Management, opening a new position worth an estimated $404K. The largest seller was UBS Group, cutting an estimated $881.

  • 3 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q4 2017, up from 2 in Q3 2017.
  • Funds reported $2.56M of Motif Bio plc Warrants to Purchase ADRs stock for Q4 2017, up 51% quarter-over-quarter.
  • 1 fund opened new Motif Bio plc Warrants to Purchase ADRs positions in Q4 2017 and 0 closed out, a net change of +1 holder.
  • The largest Motif Bio plc Warrants to Purchase ADRs buyer in Q4 2017 was Sand Grove Capital Management, an estimated $404K added.
  • The largest Motif Bio plc Warrants to Purchase ADRs seller in Q4 2017 was UBS Group, an estimated $881 sold.

Based on aggregated 13F filings for Q4 2017.